PT - JOURNAL ARTICLE AU - Dingying Shan AU - Jessica Hsiung AU - Kevin P. Bliden AU - Su Zhao AU - Tao Liao AU - Guoxing Wang AU - Shuanglin Tan AU - Tiancheng Liu AU - Deepika Sreedhar AU - Jessica Kost AU - Shin Ting Chang AU - Wei Po Yuan AU - Udaya Tantry AU - Paul Gurbel AU - Meijie Tang AU - Hongjie Dai TI - A New Saliva-Based Lateral-Flow SARS-CoV-2 IgG Antibody Test for mRNA Vaccination AID - 10.1101/2021.06.11.21258769 DP - 2021 Jan 01 TA - medRxiv PG - 2021.06.11.21258769 4099 - http://medrxiv.org/content/early/2021/06/16/2021.06.11.21258769.short 4100 - http://medrxiv.org/content/early/2021/06/16/2021.06.11.21258769.full AB - Sensitive detection of IgG antibodies against SARS-CoV-2 is important to assessing immune responses to viral infection or vaccination and immunity duration. Antibody assays using non-invasive body fluids such as saliva could facilitate mass testing including young children, elderly and those who resist blood draws, and easily allowing longitudinal testing/monitoring of antibodies over time. Here, we developed a new lateral flow (nLF) assay that sensitively detects SARS-CoV-2 IgG antibodies in the saliva samples of vaccinated individuals and previous COVID-19 patients. The 25-minute nLF assay detected anti-spike protein (anti-S1) IgG in saliva samples with 100% specificity and high sensitivity from both vaccinated (99.51% for samples ≥ 19 days post 1st Pfizer/BioNTech or Moderna mRNA vaccine dose) and infected individuals. Antibodies against nucleocapsid protein (anti-NCP) was detected only in the saliva samples of COVID-19 patients and not in vaccinated samples, allowing facile differentiation of vaccination from infection. SARS-CoV-2 anti-S1 IgG antibody in saliva measured by nLF demonstrated similar evolution trends post vaccination to that in matching dried blood spot (DBS) samples measured by a quantitative pGOLD lab-test, enabling the nLF to be a valid tool for non-invasive personalized monitoring of SARS-CoV-2 antibody persistence. The new salivary rapid test platform can be applied for non-invasive detection of antibodies against infection and vaccination in a wide range of diseases.Competing Interest StatementACKNOWLEDGMENTS This work was supported by Platelet and Thrombosis Research, LLC, Baltimore, MD, USA. Device fabrication was supported by Shenzhen Grant No. JSGG20191231141403880 and Guangdong Grant No. 2020B1111160003. Conflict of Interest Statement. Hongjie Dai worked on this project as a consultant to Nirmidas Biotech Inc., independent of his research at Stanford.Funding StatementThis work was supported by Platelet and Thrombosis Research, LLC, Baltimore, MD, USA. Device fabrication was supported by Shenzhen Grant No. JSGG20191231141403880 and Guangdong Grant No. 2020B1111160003.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was performed in accordance with standard ethical principles and approved by the LifeBridge Health local institutional review board under Protocol # 1707882 and clinical trials # 04910971. All patients provided written consent.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data referred to in the manuscript are available upon request to the corresponding author.